CLINICAL_TRIALS
trial_result
· 2021-06-22
Clinical Trial Update: UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission [Phase 2]
Summary
Phase 2 trial in high-risk multiple myeloma was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2021-06-22